Smart Cancer Guide

Ivermectin is a drug primarily used to treat parasitic infections, and it has attracted research interest for its potential biological effects in cancer models, particularly within integrative and experimental treatment contexts. However, current mainstream oncology guidelines do not support ivermectin as a standard or evidence-based treatment for cancer, especially as a substitute for established therapies such as immunotherapy, targeted therapy, chemotherapy, or radiation. Access to modern cancer care also remains uneven globally. Advanced diagnostic testing, molecular profiling, and novel therapies are often more accessible in high-income healthcare systems or through comprehensive insurance coverage. In contrast, patients in lower-resource or impoverished settings may face significant barriers to timely diagnosis and access to cutting-edge treatments. In this context, repurposed drugs—including ivermectin—are sometimes discussed in research and public discours...

The explosion of online integrative oncology content has created two dangerous extremes. On one side sits conventional oncology—highly evidence-backed, yet occasionally lacking personalized lifestyle integration. On the other lies a viral universe of alternative narratives built on oversimplifications, such as the claim that you can "starve" cancer by cutting out carbohydrates. The future of successful oncology is neither extreme. The modern paradigm relies on systems-based integrative oncology —a discipline that merges rigorous tumor biology, cancer metabolism, immunometabolism, and microbiome science into evidence-ranked, patient-specific protocols. This is the foundation of the Metabolic Cancer Protocol 2026 . The Core Integrative Principle: Metabolic and lifestyle interventions are not designed to replace conventional oncology. Instead, they widen the therapeutic window. By stacking these evidence-based strategies alongside standard treatments, we can optimiz...